ANRS Infectious emerging diseases (MIE), autonomous agency of Inserm, facilitates, evaluates, coordinates and funds research into HIV/AIDS, viral hepatitis, sexually transmitted infections, tuberculosis and emerging and re-emerging infectious diseases.
A central role in infectious diseases research for over 35 years
Supporting research to prevent, understand and treat infectious diseases
ANRS MIE three majors levels of action
ANRS MIE is an agency operating under the specific status of an autonomous agency within Inserm.
Patient associations, next generation of scientists, quality and ethical approach, open science
Our agency funds, coordinates, evaluates and facilitates research into HIV/AIDS, viral hepatitis, sexually transmitted infections, tuberculosis and emerging infectious diseases.
Learn more about the diseases and pathogens covered by our research
Information on the projects we fund
Our workgroups bring together researchers and representatives of civil society
Guiding and advising innovative project leaders
The agency supports a number of research platforms and networks to federate and help shape research in its field
National and international research platforms supported by the agency and designed for the scientific community
Clinical research networks and networks of young researchers
Access to data and biological collections from research promoted by the agency
The agency is a member of various networks and forges partnerships with national and international associations, organisations and initiatives
Partner sites, international global health research platforms, ad hoc partnerships
WHO, Ministry of Europe and Foreign Affairs, Global Health EDCTP3 Joint Undertaking, structuring networks
Strategic international projects and capacity-building programmes
Fighting epidemics: ANRS MIE leads WHO filovirus CORC
Collaboration with community stakeholders
Each year, the agency offers two calls for generic projects and calls for thematic projects. Some are jointly carried out with other research players
Agency's current, forthcoming and completed calls for proposals
Find out the list of calls for projects previously funded by the agency
Find out the Start programme, here to support and guide the next generation of scientific researchers
ANRS MIE is at the forefront of crisis preparedness and response.
Facilitation and watch procedure for responding to emerging or re-emerging epidemics.
This Outbreak Response Unit for several diseases is active since March 2025.
ANRS MIE continues to follow influenza closely since June 2024.
Opened since January 2025 and still active since the detection of one new case in French Guiana in January 2026.
Every Outbreak response units, active or inactive.
Submit a project
Find out successful aplications.
Last updated on 22 September 2026
Share:
Trier par
COGNE Mélanie
AAP Exceptionnel
1
1 €
COGNE Mélanie | Service de Médecine Physique et de Réadaptation Adulte COGNE Mélanie Service de Médecine Physique et de Réadaptation Adulte CHU de Rennes Hôpital Pontchaillou 2 rue Henri Le Guilloux 35000 Rennes France
Conrad Anne
30
1 300 002 €
CONRAD Anne | Service des Maladies Infectieuses et Tropicales CONRAD Anne Service des Maladies Infectieuses et Tropicales Hospices Civils de Lyon 103 Grande Rue de la Croix-Rousse 69004 Lyon France
Larmarange Joseph
12
48 847 €
LARMARANGE Joseph | Ceped (UMR 196 Université Paris Cité, IRD, Université Sorbonne Paris Nord, Inserm) LARMARANGE Joseph Ceped (UMR 196 Université Paris Cité, IRD, Université Sorbonne Paris Nord, Inserm) 45 Rue des Saints-Pères 75006 Paris France
BASTARD Paul
48
540 001 €
BASTARD Paul | U1163 IHU Institut Imagine BASTARD Paul U1163 IHU Institut Imagine Laboratoire de Génétique Humaine de Maladies Infectieuses IHU Institut Imagine 24 boulevard du Montparnasse 75015 Paris FRANCE
Melica Giovanna
36
1 265 738 €
MELICA Giovanna | Service de Maladies Infectieuses et Immunologie Clinique Virus,hepatologie, cancer MELICA Giovanna Service de Maladies Infectieuses et Immunologie Clinique Virus,hepatologie, cancer U955 Eq 18 GH Henri Mondor, APHP 1 rue Gustave Eiffel 94000 Creteil France
Balmaseda Angel
24
499 832 €
BALMASEDA Angel | Nicaragua Virology Program BALMASEDA Angel Nicaragua Virology Program Sustainable Sciences Institute LOS ROBLES, III ETAPA, SEMAF DE PLAZA EL SOL 1 C AL SUR, 2 C AL OESTE 14006 Managua Nicaragua
Roquilly Antoine
ROQUILLY Antoine | Anesthésie - Réanimation chirurgicale ROQUILLY Antoine Anesthésie - Réanimation chirurgicale Unité d'Investigation Clinique 9 - CIC 1413 CHU de Nantes 5 allée de l'Ile Gloriette 44093 Nantes France
Boyer Pierre
BOYER Pierre | Pathogens Host Arthropod Vectors Interfaces (PHAVI) BOYER Pierre Pathogens Host Arthropod Vectors Interfaces (PHAVI) Team 3: Tick-Borne Bacterial Infection and human susceptibility 1-3 rue koeberlé 67000 Strasbourg France
Tattevin Pierre
TATTEVIN Pierre | CIC 1414 TATTEVIN Pierre CIC 1414 rue Le guilloux 35033 Rennes France
